Targeting the C-C Motif Chemokine Ligand 2 (CCL2) and C-C Motif Chemokine Receptor 2 (CCR2) pathways in a lung adenocarcinoma mouse model led to reduced recruitment of M2 macrophages and inhibited tumor growth (79). This evidence concerns the gene CCR2 and neoplasm.